TriAgenics Extends Latest Funding Round

2025-09-26

TriAgenics, Inc., a privately held company pioneering a non-surgical approach to third molar (wisdom tooth) prevention, today announced that it expanded its Series B-1 funding

TriAgenics Raises $3M for FDA Push

2025-07-21

TriAgenics, Inc., a privately held medical device company pioneering a non-surgical approach to third molar (wisdom tooth) prevention, recently announced the closing of a $3

TriAgenics Appoints New CEO

2025-04-28

TriAgenics, Inc., pioneer of Zero3 TBA, a fully guided tooth bud ablation system designed to prevent third molar formation, announced that David Thrower has been